ArticlePituitary2025
Posterior pituitary tumors: an entity unto itself.
Article in Pituitary, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A third ventricular floor-associated TTF-1-positive posterior pituitary tumor: illustrative case.Journal of neurosurgery. Case lessons · 2026Article
- TTF-1-positive primary papillary epithelial tumor of the sella with long-term recurrence after multiple resections.JCEM case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Posterior pituitary tumors (PPT) are rare, benign tumors but may lead to compromised hypothalamic and pituitary function. A new study by Kremenevski et al. presents a single institution experience of these tumors, namely, pituicytomas, spindle cell oncocytomas, and granular cell tumors. They incorporate the revised 2022 WHO classification and highlight the preoperative and postoperative endocrine, metabolic, and radiologic outcomes of PPT. This study adds to our knowledge in this rare subset of tumors and underscores the need for ongoing surveillance for hypopituitarism and hypothalamic obesity.
Indexed as
Identifiers
40379998What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.